Verona Pharma (Verona Pharma) Ending Cash Position : $254.88 Mil (As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Verona Pharma Ending Cash Position?

Verona Pharma's Ending Cash Position for the quarter that ended in Mar. 2024 was $254.88 Mil.

Verona Pharma's quarterly Ending Cash Position increased from Sep. 2023 ($257.37 Mil) to Dec. 2023 ($271.77 Mil) but then declined from Dec. 2023 ($271.77 Mil) to Mar. 2024 ($254.88 Mil).

Verona Pharma's annual Ending Cash Position increased from Dec. 2021 ($148.38 Mil) to Dec. 2022 ($227.83 Mil) and increased from Dec. 2022 ($227.83 Mil) to Dec. 2023 ($271.77 Mil).

Verona Pharma Ending Cash Position Historical Data

The historical data trend for Verona Pharma's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verona Pharma Ending Cash Position Chart

Verona Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

30.43

187.99

148.38

227.83

271.77

Verona Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															291.42	270.73	257.37	271.77	254.88

Verona Pharma Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Verona Pharma's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	227.827	+	43.945
	=	271.77

Verona Pharma's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	271.772	+	-16.89
	=	254.88

Verona Pharma Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Verona Pharma's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Verona Pharma (Verona Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verona Pharma PLC (GREY:VNAPF) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

VRNA:USA I9SA:Germany

Address

3 More London Riverside, London, GBR, SE1 2RE

Website

https://www.veronapharma.com

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma. The company is engaged in pharmaceutical development.